The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, pivotal trial of microbubble-enhanced transcranial focused ultrasound (MB-FUS) for plasma-based liquid biopsy in patients with glioblastoma (LIBERATE).
 
Manmeet Ahluwalia
Stock and Other Ownership Interests - doctible; MedInnovate Advisors LLC; MimiVax; TriSalus Life Sciences
Honoraria - Elsevier; Peerview; Prime Education; Prime Oncology
Consulting or Advisory Role - AlloVir; Anheart Therapeutics; Apollomics; Autem Therapeutics; Bayer; Bugworks; Cairn Therapeutics; Caris Life Sciences; Equillium; GlaxoSmithKline; InSightec; Janssen; Menarini Group; Modifi Bio; NH TherAguix; Nuvation Bio; Prelude Therapeutics; Pyramid Biosciences; SDP Oncology; Siemens Healhineers/Varian Medical Systems; Sumitomo Dainippon Pharma Oncology; ViewRay; Voyager Therapeutics; Xoft
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst); Seagen (Inst)
Other Relationship - Idorsia (I); ResMed (I)
 
Ahmad Ozair
No Relationships to Disclose
 
Terence Burns
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Neurametrix (Inst); Predicine (Inst); SERVIER (Inst)
Research Funding - Abbvie (Inst); Aminex Therapeutics (Inst); Boehringer Ingelheim (Inst); Codman (Inst); Insightec (Inst); MetVital (Inst); Predicine (Inst); SonaCare Medical (Inst)
Patents, Royalties, Other Intellectual Property - Methods and Materials for Treating Cancer. US Application PCT/US2022/026434 (Inst); Patent 3887685: Drug Delivery and Biomarker Access Devices (Inst)
 
Michael McDermott
Stock and Other Ownership Interests - Diende; Light helmets
Honoraria - Insightec; Insightec
Consulting or Advisory Role - Diende; Insight tech; Insight tech; Light Helmet; Stryker
Patents, Royalties, Other Intellectual Property - Royalties from Limitorr CSF reservoir sales excluding my institution; manufacturer Integra Lifesciences; patent rights signed over to University of California many years ago
 
Alon Mogilner
No Relationships to Disclose
 
Bhavya Shah
No Relationships to Disclose
 
Toral Patel
Research Funding - CarThera (Inst); GT Medical Technologies (Inst); InSightec (Inst); Plus Therapeutics (Inst)
 
Jordina Rincon-Torroella
No Relationships to Disclose
 
Mark Mishra
No Relationships to Disclose
 
Richard Everson
No Relationships to Disclose
 
Justin Hilliard
No Relationships to Disclose
 
Yarema Bezchlibnyk
No Relationships to Disclose
 
Matthew Hibert
Employment - InSightec
Stock and Other Ownership Interests - InSightec
 
Julia Zhu
Employment - InSightec
 
Jeffrey Weinberg
No Relationships to Disclose
 
Christopher Cifarelli
Honoraria - Carl Zeiss Meditec
 
Ali Rezai
No Relationships to Disclose
 
Vibhor Krishna
No Relationships to Disclose
 
Nir Lipsman
No Relationships to Disclose
 
Graeme Woodworth
Research Funding - Insightec (Inst)
Patents, Royalties, Other Intellectual Property - Nanomedicines for Cancer therapy
Travel, Accommodations, Expenses - Brainlab (Inst)
(OPTIONAL) Uncompensated Relationships - Sonoalasense
 
LIBERATE Trial Investigators
No Relationships to Disclose